Emergent Invasive Group A Streptococcus dysgalactiae subsp. equisimilis, United States, 2015-2018.

ABCs Active Bacterial Core surveillance GAS Lancefield group A antigen Streptococccus equisimilis Streptococcus dysgalactiae Streptococcus pyogenes bacteria bacterial infections invasive group A Streptococcus multilocus sequence type streptococci

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 4 6 2019
medline: 24 12 2019
entrez: 4 6 2019
Statut: ppublish

Résumé

The term group A Streptococcus is considered synonymous for the species Streptococcus pyogenes. We describe an emergent invasive S. dysgalactiae subspecies equisimilis lineage that obtained the group A antigen through a single ancestral recombination event between a group C S. dysgalactiae subsp. equisimilis strain and a group A S. pyogenes strain.

Identifiants

pubmed: 31158071
doi: 10.3201/eid2508.181758
pmc: PMC6649341
doi:

Substances chimiques

Virulence Factors 0

Types de publication

Historical Article Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1543-1547

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Références

J Clin Microbiol. 1999 Dec;37(12):4194-7
pubmed: 10565964
Infect Immun. 2001 Apr;69(4):2416-27
pubmed: 11254602
J Clin Microbiol. 2008 Apr;46(4):1526-9
pubmed: 18305132
Clin Infect Dis. 2009 Mar 15;48(6):706-12
pubmed: 19187026
J Clin Microbiol. 2009 Jul;47(7):2046-54
pubmed: 19386831
J Exp Med. 1928 Jan 1;47(1):91-103
pubmed: 19869404
PLoS One. 2010 Jul 23;5(7):e11741
pubmed: 20668530
Cell Host Microbe. 2014 Jun 11;15(6):729-740
pubmed: 24922575
MBio. 2017 Sep 19;8(5):
pubmed: 28928212
Clin Infect Dis. 2019 Feb 5;:null
pubmed: 30721938
Immunochemistry. 1978 Nov;15(10-11):755-60
pubmed: 85600

Auteurs

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH